Transparent Cap-Assisted Colonoscopy Combined With Computer-Aided Detection in Improving the Detection Rate of Colorectal Adenomas
NCT ID: NCT07097350
Last Updated: 2025-07-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
524 participants
INTERVENTIONAL
2025-08-01
2027-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Randomize into 2 interventional groups based on Random function of Statistical Package for the Social Sciences (SPSS) 20.0, including (1) Group 1: computer-aided detection alone and (2) Group 2: transparent cap-assisted computer-aided detection.
3. Collecting variables which consist of primary and secodary outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
computer-aided detection alone
colonoscopy with computer-aided detection alone
computer-aided detection alone
colonoscopy with computer-aided detection
transparent cap-assisted colonoscopy combined with computer-aided detection
transparent cap-assisted colonoscopy combined with computer-aided detection
transparent cap-assisted colonoscopy combined with computer-aided detection
transparent cap-assisted colonoscopy combined with computer-aided detection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
computer-aided detection alone
colonoscopy with computer-aided detection
transparent cap-assisted colonoscopy combined with computer-aided detection
transparent cap-assisted colonoscopy combined with computer-aided detection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with highly suspected or pathologically confirmed colorectal cancer
* Patients presenting with alarm symptoms or signs (hematochezia, melena, unexplained anemia or weight loss, palpable abdominal mass, or a positive digital rectal examination)
* Pregnant or breastfeeding women
* Patients with gastrointestinal obstruction
* Patients with inflammatory bowel disease, familial adenomatous polyposis, or serrated polyposis syndrome
* Patients who have taken anticoagulants (e.g., aspirin, warfarin) within 7 days before colonoscopy or who have coagulation disorders
* Patients currently enrolled in another clinical study or who participated in any clinical trial within the past 60 days
* Insertion failure for any reason (e.g., scope cannot pass an obstruction, patient cannot tolerate the procedure) or colonoscopy not reaching the cecum
* A Boston Bowel Preparation Scale (BBPS) score \< 6 at scope insertion (inadequate preparation requiring repeat bowel cleansing)
* Use of non-guideline-recommended bowel preparation agents
* Patients undergoing emergency colonoscopy
45 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fudan University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhijun Bao
Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Danian Ji, M.D.
Role: STUDY_DIRECTOR
Huadong Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huadong hospital, Fudan university
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Danian Ji, M.D.
Role: primary
Zhiyu Dong, M.D.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025K239
Identifier Type: -
Identifier Source: org_study_id